Home/Filings/4/0001140361-24-032525
4//SEC Filing

MATHIESEN JEFFREY S 4

Accession 0001140361-24-032525

CIK 0001610853other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 5:00 PM ET

Size

5.7 KB

Accession

0001140361-24-032525

Insider Transaction Report

Form 4
Period: 2024-07-02
MATHIESEN JEFFREY S
DirectorCFO and Treasurer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-07-02+404,000404,000 total
    Exercise: $0.96Exp: 2034-07-01Class A Common Stock (404,000 underlying)
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 62.5% of the options vested immediately upon grant, and the remaining options vest in a series of ten (10) successive equal quarterly installments on the last day of each quarter starting on September 30, 2024, subject to the Reporting Person's continued service through each applicable vesting period.

Issuer

HELIUS MEDICAL TECHNOLOGIES, INC.

CIK 0001610853

Entity typeother

Related Parties

1
  • filerCIK 0001296853

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:00 PM ET
Size
5.7 KB